Arrivent Biopharma, a clinical-stage biopharmaceutical company, has recently appointed Dr. Merdad Parsey, M.D., Ph.D., to its board of directors. Dr. Parsey has extensive executive experience in ...

Perhaps no industry is as reliant on grant-funded university research as is bioscience, the companies that develop ...

Hansa Biopharma AB appointed Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately. Søren Tulstrup ...

UPS is expanding its precision logistics capabilities in the pharmaceutical and life sciences sectors with an agreement to purchase Andlauer Healthcare Group in Canada.

Where thousands of former Health and Human Services employees will work next is unknown, but biopharma companies likely ...

It is critically important for the Trump administration to combat this freeloading. However, given the complexities of international pharmaceutical markets and the inherent power imbalance between ...

Roche projected that its $50 billion manufacturing investment, to include R&D operations, will generate 1,000 jobs at the ...

Quantum BioPharma announces the appointment of Kevin Malone as an advisor to the Board of Directors. Stay Ahead of the Market: Discover ...

Scott Lyman, CEO of Belhaven Biopharma, expressed enthusiasm about the results, stating, "The successful outcomes of this dose confirmation and allergic rhinitis study clears the way for our pivotal ...

Assess today's live Mereo BioPharma Group PLC ADR (MREO) share price, performance and insights using our live NASDAQ: MREO stock exchange data. Analyse the historical data and Mereo BioPharma Group ...

Wellington Management Group LLP purchased a new stake in shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP – Free Report) during the fourth quarter, Holdings Channel reports. The fund purchased ...

MANILA, Philippines – The head of a local group of pharmaceutical firms has expressed confidence that US President Donald Trump’s new tariff policy will have minimal impact on their sector ...